Ksienski, Doran https://orcid.org/0000-0001-6300-8294
Truong, Pauline T.
Bone, Jeffrey N.
Egli, Sarah
Clarkson, Melissa
Patterson, Tiffany
Lesperance, Mary
Lakkunarajah, Suganija
Funding for this research was provided by:
AstraZeneca
Article History
Accepted: 14 October 2024
First Online: 4 November 2024
Declarations
:
: This manuscript was funded by an unrestricted educational grant from AstraZeneca Canada.
: Dr. Doran Ksienski has received an unrestricted educational grant from AstraZeneca, Canada. Dr. Pauline Truong receives writing and royalty fees from UpToDate, Wolster Kluwer Health Publishing. Jeffrey N. Bone, Sarah Egli, Melissa Clarkson, and Tiffany Patterson declare that they have no conflicts of interest that might be relevant to the contents of this manuscript.
: This study was approved by the University of British Columbia Research Ethics Board (H23-03908) and a waiver of consent was granted.
: Not applicable.
: The datasets generated and/or analyzed during the current study are available from the corresponding author upon reasonable request.
: Not applicable.
: Conception and design: D. Ksienski, P. Truong, J. Bone, M. Lesperance, and S. Lakkunarajah. Data collection: S. Lakkunarajah, D. Ksienski, M. Clarkson, and S. Egli. Analyses and interpretation of data: D. Ksienski, J. Bone, P. Truong, M. Lesperance, and S. Lakkunarajah. Manuscript writing: D. Ksienski, P. Truong, J. Bone, M. Lesperance, T. Patterson, and S. Lakkunarajah. Approval of final article: all authors read and approved the final manuscript.